phorbols has been researched along with Adrenal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Virgilio, F; Meldolesi, J; Pozzan, T; Vicentini, LM; Wollheim, CB | 1 |
| Daly, JW; Hollingsworth, EB; Ukena, D | 1 |
2 other study(ies) available for phorbols and Adrenal Cancer
| Article | Year |
|---|---|
Tumor promoter phorbol myristate acetate inhibits Ca2+ influx through voltage-gated Ca2+ channels in two secretory cell lines, PC12 and RINm5F.
Topics: Adrenal Gland Neoplasms; Animals; Calcium; Cell Line; Insulin; Insulin Secretion; Ion Channels; Membrane Potentials; Pheochromocytoma; Phorbols; Potassium; Rats; Tetradecanoylphorbol Acetate | 1986 |
The protein kinase C activator phorbol-12-myristate-13-acetate enhances cyclic AMP accumulation in pheochromocytoma cells.
Topics: 2-Chloroadenosine; Adenosine; Adrenal Gland Neoplasms; Animals; Cell Line; Colforsin; Cyclic AMP; Enzyme Activation; Pheochromocytoma; Phorbols; Phosphatidylinositols; Protein Kinase C; Rats; Stimulation, Chemical; Tetradecanoylphorbol Acetate | 1986 |